These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thinking outside the synapse: pharmacokinetic-based medications for cocaine addiction. Czoty PW; Roberts DC Neuropsychopharmacology; 2012 Apr; 37(5):1079-80. PubMed ID: 22071873 [No Abstract] [Full Text] [Related]
5. Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood. Guerriero RM; Hayes MM; Dhaliwal SK; Ren JQ; Kosofsky BE Biol Psychiatry; 2006 Dec; 60(11):1171-80. PubMed ID: 16780809 [TBL] [Abstract][Full Text] [Related]
8. Cocaine pharmacology and current pharmacotherapies for its abuse. Carrera MR; Meijler MM; Janda KD Bioorg Med Chem; 2004 Oct; 12(19):5019-30. PubMed ID: 15351386 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. del Castillo C; Morales L; Alguacil LF; Salas E; Garrido E; Alonso E; Pérez-García C Neuropharmacology; 2009 Jul; 57(1):41-8. PubMed ID: 19393250 [TBL] [Abstract][Full Text] [Related]
10. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268 [TBL] [Abstract][Full Text] [Related]
11. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Schmidt HD; Pierce RC Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308 [TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Platt DM; Rowlett JK; Spealman RD Psychopharmacology (Berl); 2002 Oct; 163(3-4):265-82. PubMed ID: 12373428 [TBL] [Abstract][Full Text] [Related]
13. Development of a therapeutic vaccine for the treatment of cocaine addiction. Fox BS Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013 [TBL] [Abstract][Full Text] [Related]
14. Cocaine-evoked synaptic plasticity: a key to addiction? Lüscher C; Bellone C Nat Neurosci; 2008 Jul; 11(7):737-8. PubMed ID: 18575469 [No Abstract] [Full Text] [Related]
15. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. Gyertyán I; Kiss B; Gál K; Laszlovszky I; Horváth A; Gémesi LI; Sághy K; Pásztor G; Zájer M; Kapás M; Csongor EA; Domány G; Tihanyi K; Szombathelyi Z J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312 [TBL] [Abstract][Full Text] [Related]
16. Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior. Doron R; Fridman L; Yadid G Neuroreport; 2006 Oct; 17(15):1633-6. PubMed ID: 17001283 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat. Schmidt HD; Anderson SM; Pierce RC Eur J Neurosci; 2006 Jan; 23(1):219-28. PubMed ID: 16420431 [TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking. Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883 [TBL] [Abstract][Full Text] [Related]
19. Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration. Grasing K; He S; Yang Y Pharmacol Biochem Behav; 2009 Nov; 94(1):169-78. PubMed ID: 19698738 [TBL] [Abstract][Full Text] [Related]